DR MARCELLO BELLUSCI

Dr Bellusci received his MD from the Faculty of Medicine at the Alma Studiorum University of Bologna and completed his residency in Pediatrics at University Hospital 12 de Octubre in Madrid, where he also specialized as a Pediatric Neurologist.
As a specialist in metabolic diseases, Dr Bellusci realized his training in 3 groups belonging to the European reference networks: the MetabERN group of H. 12 de Octubre in Madrid and also the MetabERN and the EpiCARE groups of the Bambino Gesu Pediatric Hospital in Rome.

Experienced with all kinds of hereditary metabolic disorders, he is especially focused on the study and treatment of primary mitochondrial diseases. Dr Bellusci is the leading clinician of the spanish mitochondrial diseases patients registry and the MitoSpain collaborative working group in mitochondrial diseases. He is principal investigator and co-investigator in translational projects for new biomarkers and new treatments for mitochondrial diseases patients. As a member of the pediatric clinical trials unit at 12 de Octubre Hospital, he also acquired experience on advanced therapies, as new genetic therapies for inherited metabolic disorders, including lysosomal diseases, organic acidurias, urea cycle disorders, glycogen storage diseases. Author of more than 50 national and international talks on inherited metabolic diseases, more than 20 indexed scientific articles and book chapters, reviewer of scientific journals indexed in first quartile.​ Teaching metabolic medicine at the Complutense University. He is also member of the following scientific committees: MetabERN mitochondrial diseases subnetwork, GENOMIT network, association of spanish patients with mitochondrial diseases (AEPMI), CIBERER unified registry for rare diseases. He is member of the Society for the Study of Inborn Errors of Metabolism (SSIEM) and of the Spanish Association for the Study of Inborn Errors of Metabolism (AECOM).